PMID- 26668670 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20151215 LR - 20201001 IS - 1874-3129 (Print) IS - 1874-3129 (Electronic) IS - 1874-3129 (Linking) VI - 9 DP - 2015 TI - Intravenous Immune Globulin in Amyopathic Dermatomyositis - Report of Two Cases and Review of the Literature. PG - 77-81 LID - 10.2174/1874312901409010077 [doi] AB - Amyopathic dermatomyositis (ADM) is a rare subtype of dermatomyositis which is often recalcitrant to immune suppressing treatments. Intravenous immunoglobulin (IVIG) has been used in the treatment of refractory dermatomyositis. We present two patients with severe ADM, who were treated with IVIG at 2 g/kg every four weeks. Both patients had a successful response and were able to taper the dosage of prednisone. We present both cases in describing IVIG as a rescue and maintenance steroid-sparing agent in the treatment of severe refractory ADM. We also review the treatment of refractory ADM with IVIg in the English literature. FAU - Cafardi, John M AU - Cafardi JM AD - The Christ Hospital and The University of Cincinnati Medical Center, USA. FAU - Sami, Naveed AU - Sami N AD - Department of Dermatology, The University of Alabama at Birmingham, USA. LA - eng PT - Journal Article DEP - 20151104 PL - United Arab Emirates TA - Open Rheumatol J JT - The open rheumatology journal JID - 101480507 PMC - PMC4676053 OTO - NOTNLM OT - Intravenous immunoglobulin OT - amyopathic dermatomyositis OT - direct immunofluorescence. OT - treatment EDAT- 2015/12/17 06:00 MHDA- 2015/12/17 06:01 PMCR- 2015/01/01 CRDT- 2015/12/16 06:00 PHST- 2015/04/23 00:00 [received] PHST- 2015/09/23 00:00 [revised] PHST- 2015/09/23 00:00 [accepted] PHST- 2015/12/16 06:00 [entrez] PHST- 2015/12/17 06:00 [pubmed] PHST- 2015/12/17 06:01 [medline] PHST- 2015/01/01 00:00 [pmc-release] AID - TORJ-9-77 [pii] AID - 10.2174/1874312901409010077 [doi] PST - epublish SO - Open Rheumatol J. 2015 Nov 4;9:77-81. doi: 10.2174/1874312901409010077. eCollection 2015.